BioXcel Therapeutics, Inc. (BTAI) Return on equity
BioXcel Therapeutics, Inc. (BTAI) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-215.9%FY2022
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -215.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice